elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26745771-00E6B197-ADB2-4A8B-84BA-A4DA2B6ECDDB
Q26745771-00E6B197-ADB2-4A8B-84BA-A4DA2B6ECDDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745771-00E6B197-ADB2-4A8B-84BA-A4DA2B6ECDDB
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
P2860
Q26745771-00E6B197-ADB2-4A8B-84BA-A4DA2B6ECDDB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745771-00E6B197-ADB2-4A8B-84BA-A4DA2B6ECDDB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21db403cf5349bb21db14f70ba876bb5f87686ff
P2860
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.